Epithelial mesenchymal transition

From WikiMD.org
Jump to navigation Jump to search

Epithelial Mesenchymal Transition (pronunciation: /ɛpɪˈθiːliəl mɛsənˈkaiməl trænˈsɪʃən/), often abbreviated as EMT, is a biological process that allows a polarized epithelial cell, which normally interacts with the basement membrane via its basal surface, to undergo multiple biochemical changes that enable it to assume a mesenchymal cell phenotype, which includes enhanced migratory capacity, invasiveness, resistance to apoptosis, and greatly increased production of extracellular matrix components.

Etymology

The term "Epithelial Mesenchymal Transition" is derived from the names of the two cell types involved in the process: epithelial cells and mesenchymal cells. The word "transition" refers to the transformation that occurs between these two cell types.

Process

The process of EMT is often triggered by various chemical signals, such as transforming growth factor beta (TGF-β), tumor necrosis factor-alpha (TNF-α), and interleukin-6 (IL-6), which activate transcription factors that lead to EMT. These transcription factors include Snail, Slug, ZEB1, and ZEB2, which repress E-cadherin, causing the cells to lose their cell-cell adhesion and become more migratory.

Clinical Significance

EMT is essential for numerous developmental processes including mesoderm formation and neural tube formation. EMT has also been implicated in wound healing, and organ fibrosis. In disease, EMT has been recognized as a crucial part of the progression of cancer into an invasive state.

Related Terms

External links

Esculaap.svg

This WikiMD article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski